How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Living Donor Protection Act of 2017
Client: AMERICAN NEPHROLOGY NURSES' ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1270- the Living Donor Protection Act
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · 1A
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN NEPHROLOGY NURSES' ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
Source: Senate LDA
| PATIENT ACCESS NETWORK FOUNDATION |
| 3 |
| 2017–2018 |
| ALLIANCE FOR AGING RESEARCH | 2 | 2017 |
| NATIONAL ASSOCIATION OF SPECIALTY PHARMACY | 2 | 2017–2018 |
| SPINA BIFIDA ASSOCIATION | 1 | 2018 |
| THE REHABILITATION INNOVATION CENTERS COALITION | 1 | 2018 |
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Consolidated Appropriations Act, 2018
Client: SPINA BIFIDA ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
FY 2018 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the Centers for Disease Control (CDC); H.R. 1625, the Consolidated Appropriations Act, FY 2019 Health and Human Services (HHS) appropriations supporting the NSBP at the CDC.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: AMERICAN NEPHROLOGY NURSES' ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Home Health Care Planning Improvement Act; S.1890/ H.R. 2644- Chronic Kidney Disease Improvement in Research and Treatment Act; H.R. 3166, To amend title XVIII of the Social Security Act to provide under the Medicare program for independent accreditation for dialysis facilities and assurance of high quality surveys with respect to such facilities; S 1729- the Dialysis Access Improvement Act.
To amend title XVIII of the Social Security Act to provide under the Medicare program for independent accreditation for dialysis facilities and assurance of high quality surveys with respect to such facilities.
Client: AMERICAN NEPHROLOGY NURSES' ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Home Health Care Planning Improvement Act; S.1890/ H.R. 2644- Chronic Kidney Disease Improvement in Research and Treatment Act; H.R. 3166, To amend title XVIII of the Social Security Act to provide under the Medicare program for independent accreditation for dialysis facilities and assurance of high quality surveys with respect to such facilities; S 1729- the Dialysis Access Improvement Act.
Preserving Rehabilitation Innovation Centers Act of 2017
Client: THE REHABILITATION INNOVATION CENTERS COALITION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Impatient Rehabilitation Issues; HR 4582/ S 2204 Preserving Rehabilitation Innovation Centers Act.
Dialysis Access Improvement Act of 2017
Client: AMERICAN NEPHROLOGY NURSES' ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Home Health Care Planning Improvement Act; S.1890/ H.R. 2644- Chronic Kidney Disease Improvement in Research and Treatment Act; H.R. 3166, To amend title XVIII of the Social Security Act to provide under the Medicare program for independent accreditation for dialysis facilities and assurance of high quality surveys with respect to such facilities; S 1729- the Dialysis Access Improvement Act.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: AMERICAN NEPHROLOGY NURSES' ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Home Health Care Planning Improvement Act; S.1890/ H.R. 2644- Chronic Kidney Disease Improvement in Research and Treatment Act; H.R. 3166, To amend title XVIII of the Social Security Act to provide under the Medicare program for independent accreditation for dialysis facilities and assurance of high quality surveys with respect to such facilities; S 1729- the Dialysis Access Improvement Act.
Preserving Rehabilitation Innovation Centers Act of 2017
Client: THE REHABILITATION INNOVATION CENTERS COALITION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Impatient Rehabilitation Issues; HR 4582/ S 2204 Preserving Rehabilitation Innovation Centers Act.
Living Donor Protection Act of 2017
Client: AMERICAN NEPHROLOGY NURSES' ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1270- the Living Donor Protection Act
Living Donor Protection Act of 2017
Client: AMERICAN NEPHROLOGY NURSES' ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1270- the Living Donor Protection Act
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Cancer Drug Parity Act of 2017
Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
H.R. 1409 The Cancer Drug Parity Act
Medical Device Tax; H.R. 1628 American Health Care Act; FDA User Fee Act Reauthorization.
Medical Device Tax; H.R. 1628 American Health Care Act; FDA User Fee Act Reauthorization; Border Adjustment Tax.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: AMERICAN NEPHROLOGY NURSES' ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Home Health Care Planning Improvement Act; S.1890/ H.R. 2644- Chronic Kidney Disease Improvement in Research and Treatment Act; H.R. 3166/ S 1729- the Dialysis Access Improvement Act.
To amend title XVIII of the Social Security Act to provide under the Medicare program for independent accreditation for dialysis facilities and assurance of high quality surveys with respect to such facilities.
Client: AMERICAN NEPHROLOGY NURSES' ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Home Health Care Planning Improvement Act; S.1890/ H.R. 2644- Chronic Kidney Disease Improvement in Research and Treatment Act; H.R. 3166/ S 1729- the Dialysis Access Improvement Act.
To amend title XVIII of the Social Security Act to provide under the Medicare program for independent accreditation for dialysis facilities and assurance of high quality surveys with respect to such facilities.
Client: AMERICAN NEPHROLOGY NURSES' ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Home Health Care Planning Improvement Act; Chronic Kidney Care Act; Introduction of Chronic Kidney Disease Improvement in Research and Treatment Act; H.R. 3166/ S 1729- the Dialysis Access Improvement Act.
Expressing support for the designation of February 22, 2017, as "National Heart Valve Disease Awareness Day", coinciding with American Heart Month.
Client: ALLIANCE FOR AGING RESEARCH · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Heart valve disease awareness; H. Res 146 Resolution in support of Heart Valve Disease Awareness Day.
Expressing support for the designation of February 22, 2017, as "National Heart Valve Disease Awareness Day", coinciding with American Heart Month.
Client: ALLIANCE FOR AGING RESEARCH · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Heart valve disease awareness; H. Res 146 Resolution in support of Heart Valve Disease Awareness Day.
Dialysis Access Improvement Act of 2017
Client: AMERICAN NEPHROLOGY NURSES' ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Home Health Care Planning Improvement Act; Chronic Kidney Care Act; Introduction of Chronic Kidney Disease Improvement in Research and Treatment Act; H.R. 3166/ S 1729- the Dialysis Access Improvement Act.
Dialysis Access Improvement Act of 2017
Client: AMERICAN NEPHROLOGY NURSES' ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Home Health Care Planning Improvement Act; S.1890/ H.R. 2644- Chronic Kidney Disease Improvement in Research and Treatment Act; H.R. 3166/ S 1729- the Dialysis Access Improvement Act.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
Client: AMERICAN NEPHROLOGY NURSES' ASSOCIATION · Firm: FAEGRE DRINKER BIDDLE & REATH LLP
Home Health Care Planning Improvement Act; S.1890/ H.R. 2644- Chronic Kidney Disease Improvement in Research and Treatment Act; H.R. 3166/ S 1729- the Dialysis Access Improvement Act.
H.R. 1270- the Living Donor Protection Act
Home Health Care Planning Improvement Act; S.1890/ H.R. 2644- Chronic Kidney Disease Improvement in Research and Treatment Act; H.R. 3166, To amend title XVIII of the Social Security Act to provide under the Medicare program for independent accreditation for dialysis facilities and assurance of high quality surveys with respect to such facilities; S 1729- the Dialysis Access Improvement Act.
NATIONAL ASSOCIATION OF SPECIALTY PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
Medicare Direct and Indirect Remuneration; Drug Pricing Issues.
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · 1A
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPINA BIFIDA ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
FY 2018 Health and Human Services (HHS) appropriations supporting the National Spina Bifida Program at the Centers for Disease Control (CDC); H.R. 1625, the Consolidated Appropriations Act, FY 2019 Health and Human Services (HHS) appropriations supporting the NSBP at the CDC.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
340B federal drug pricing program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
FY 2019 Labor, Health and Human Services and Education Appropriations bill regarding National Institute of Diabetes, Digestive and Kidney Disease Funding; Funding for the Centers of Disease Control and Prevention's National Diabetes Prevention Program and Division of Diabetes Translation; FY 2019 Department of Defense appropriations peer review medical research funding.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
CONVATEC via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
Medicare Coverage and Reimbursement for technology in home care; Medicare Advantage; Medicaid Managed Care.
Medical Device Tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE REHABILITATION INNOVATION CENTERS COALITION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
Impatient Rehabilitation Issues; HR 4582/ S 2204 Preserving Rehabilitation Innovation Centers Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENT ACCESS NETWORK FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
Patient assistance programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2018 · first_quarter · Q1
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · Q4
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · Q4
340B federal drug pricing program
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
PATIENT ACCESS NETWORK FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · Q4
Patient assistance programs.
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL ASSOCIATION OF SPECIALTY PHARMACY via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · RR
Medicare Part D
CONVATEC via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · Q4
Medicare Coverage and Reimbursement for technology in home care.
Medical Device Tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN NEPHROLOGY NURSES' ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · Q4
Home Health Care Planning Improvement Act; S.1890/ H.R. 2644- Chronic Kidney Disease Improvement in Research and Treatment Act; H.R. 3166/ S 1729- the Dialysis Access Improvement Act.
H.R. 1270- the Living Donor Protection Act
AMERICAN DIABETES ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · Q4
FY 2018 Labor, Health and Human Services and Education Appropriations bill regarding National Institute of Diabetes, Digestive and Kidney Disease Funding; Funding for the Centers of Disease Control and Prevention's National Diabetes Prevention Program and Division of Diabetes Translation; FY 2018 Department of Defense appropriations peer review medical research funding; National Defense Authorization Act of 2017.
Filing targets: Natl Institutes of Health (NIH)
PATIENT ACCESS NETWORK FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · fourth_quarter · RR
Introduction of the Patient Access Network Foundation
AMERICAN NEPHROLOGY NURSES' ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · third_quarter · Q3
Home Health Care Planning Improvement Act; Chronic Kidney Care Act; Introduction of Chronic Kidney Disease Improvement in Research and Treatment Act; H.R. 3166/ S 1729- the Dialysis Access Improvement Act.
H.R. 1270- the Living Donor Protection Act
FY 18 Labor, Health, and Human Services and Education Bill, provisions regarding biomedical research; HRSA funding.
Filing targets: SENATE
CONVATEC via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · third_quarter · Q3
Medicare Coverage and Reimbursement for technology in home care; White House Proclamation on Ostomy Awareness.
Medical Device Tax; Border Adjustment Tax.
Filing targets: HOUSE OF REPRESENTATIVES
CONVATEC via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · second_quarter · 2A
Medicare Coverage and Reimbursement for technology in home care
Medical Device Tax; H.R. 1628 American Health Care Act; FDA User Fee Act Reauthorization.
Border Adjustment Tax; Medical Device Tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · third_quarter · Q3
340B federal drug pricing program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · third_quarter · Q3
FY 2017/2018 Labor, Health and Human Services and Education Appropriations bill regarding National Institute of Diabetes, Digestive and Kidney Disease Funding; Funding for the Centers of Disease Control and Prevention's National Diabetes Prevention Program and Division of Diabetes Translation; FY 2017/2018 Department of Defense appropriations peer review medical research funding; National Defense Authorization Act of 2017.
Filing targets: SENATE
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · third_quarter · Q3
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF BIOANALYSTS via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · second_quarter · Q2
Medicare Reimbursement for Clinical Laboratories; Clinical Laboratory Fee Schedule Reform; Medicare Coding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CONVATEC via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · second_quarter · Q2
Medical Device Tax; H.R. 1628 American Health Care Act; FDA User Fee Act Reauthorization; Border Adjustment Tax.
Medicare Coverage and Reimbursement for technology in home care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · second_quarter · Q2
340B federal drug pricing program
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR AGING RESEARCH via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · first_quarter · 1T
Heart valve disease awareness; H. Res 146 Resolution in support of Heart Valve Disease Awareness Day.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · second_quarter · Q2
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · second_quarter · Q2
FY 2017/2018 Labor, Health and Human Services and Education Appropriations bill regarding National Institute of Diabetes, Digestive and Kidney Disease Funding; Funding for the Centers of Disease Control and Prevention's National Diabetes Prevention Program and Division of Diabetes Translation; FY 2017/2018 Department of Defense appropriations peer review medical research funding.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
340B HEALTH via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · second_quarter · RR
340B federal drug pricing program
AMERICAN ASSOCIATION OF BIOANALYSTS via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · first_quarter · Q1
Medicare Reimbursement for Clinical Laboratories; Clinical Laboratory Fee Schedule Reform; Medicare Coding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR AGING RESEARCH via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · first_quarter · Q1
Heart valve disease awareness; H. Res 146 Resolution in support of Heart Valve Disease Awareness Day.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL MYELOMA FOUNDATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · first_quarter · Q1
H.R. 1409 The Cancer Drug Parity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN DIABETES ASSOCIATION via FAEGRE DRINKER BIDDLE & REATH LLP
2017 · first_quarter · Q1
FY 2017/2018 Labor, Health and Human Services and Education Appropriations bill regarding National Institute of Diabetes, Digestive and Kidney Disease Funding; Funding for the Centers of Disease Control and Prevention's National Diabetes Prevention Program and Division of Diabetes Translation; FY 2017/2018 Department of Defense appropriations peer review medical research funding.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
AMERICAN ASSOCIATION OF BIOANALYSTS via FAEGRE DRINKER BIDDLE & REATH LLP
2016 · fourth_quarter · Q4
Medicare Reimbursement for Clinical Laboratories; Clinical Laboratory Fee Schedule Reform, Medicare Coding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE